BGC > Buscar Producto > JD-5037 | 1392116-14-1

Molecular Formula: C27H27Cl2N5O3S

Description:
Jd-5037 is a peripherally-restricted cannabinoid inverse agonist at CB1 receptors that can be used as an anti-obesity drug, with a 700-fold higher affinity compared to CB2 receptors.

• Molecular Weight:572.5
• Purity:>98%

Molecular Formula:
C27H27Cl2N5O3S
Canonical SMILES:
CC(C)C(C(=O)N)N=C(NS(=O)(=O)C1=CC=C(C=C1)Cl)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4
InChI:
InChI=1S/C27H27Cl2N5O3S/c1-17(2)24(26(30)35)31-27(33-38(36,37)22-14-12-21(29)13-15-22)34-16-23(18-6-4-3-5-7-18)25(32-34)19-8-10-20(28)11-9-19/h3-15,17,23-24H,16H2,1-2H3,(H2,30,35)(H,31,33)/t23-,24+/m1/s1
InChIKey:
GTCSIQFTNPTSLO-RPWUZVMVSA-N
Solubility:
Soluble in DMSO.
Appearance:
Solid Powder
Storage: Store in a cool and dry place and at 0-4 ℃ for short term (days to weeks) or -66 ℃ for long term (months to years).
Synonyms:
JD 5037; JD5037; (S)-2-(((E)-((S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)((4-chlorophenyl)sulfonamido)methylene)amino)-3-methylbutanamide